SCOP Search:   
        by sunid, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: Alpha and beta proteins (a+b) (23004)
(-)
Fold: Protein kinase-like (PK-like) (2589)
(-)
Superfamily: Protein kinase-like (PK-like) (2589)
(-)
Family: Protein kinases, catalytic subunit (1977)
(-)
Protein domain: automated matches (542)
(-)
Human (Homo sapiens) [TaxId: 9606] (452)
1TVOA:THE STRUCTURE OF ERK2 IN COMPLEX WITH A SMALL MOLECULE INHIBITOR
1W7HA:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
1W82A:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
1W83A:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
1W84A:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
1WBNA:FRAGMENT BASED P38 INHIBITORS
1WBOA:FRAGMENT BASED P38 INHIBITORS
1WBSA:IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.
1WBTA:IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.
1WBVA:IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.
1WBWA:IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.
1WVWA:CRYSTAL STRUCTURES OF KINASE DOMAIN OF DAP KINASE IN COMPLEX WITH SMALL MOLECULAR INHIBITORS
1WVXA:CRYSTAL STRUCTURES OF KINASE DOMAIN OF DAP KINASE IN COMPLEX WITH SMALL MOLECULAR INHIBITORS
1WVYA:CRYSTAL STRUCTURES OF KINASE DOMAIN OF DAP KINASE IN COMPLEX WITH SMALL MOLECULAR INHIBITORS
1WZYA:CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A PYRAZOLOPYRIDAZINE DERIVATIVE
1ZWSA:; B:; C:; D:; E:; F:; G:; H:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN DRP-1 KINASE
2A27A:; B:; C:; D:; E:; F:; G:; H:HUMAN DRP-1 KINASE, W305S S308A D40 MUTANT, CRYSTAL FORM WITH 8 MONOMERS IN THE ASYMMETRIC UNIT
2BIYA:STRUCTURE OF PDK1-S241A MUTANT KINASE DOMAIN
2BKZA:; C:STRUCTURE OF CDK2-CYCLIN A WITH PHA-404611
2BPMA:; C:STRUCTURE OF CDK2-CYCLIN A WITH PHA-630529
2BR1A:STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2BRBA:STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2BRGA:STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2BRHA:STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2BRMA:STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2BRNA:STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2BROA:STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2C3JA:IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE INHIBITION OF CHK1: PREDICTION AND VERIFICATION
2C3KA:IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE INHIBITION OF CHK1: PREDICTION AND VERIFICATION
2C3LA:IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE INHIBITION OF CHK1: PREDICTION AND VERIFICATION
2C47A:; B:; C:; D:STRUCTURE OF CASEIN KINASE 1 GAMMA 2
2C4GA:; C:STRUCTURE OF CDK2-CYCLIN A WITH PHA-533514
2C6DA:AURORA A KINASE ACTIVATED MUTANT (T287D) IN COMPLEX WITH ADPNP
2C6EA:; B:AURORA A KINASE ACTIVATED MUTANT (T287D) IN COMPLEX WITH A 5-AMINOPYRIMIDINYL QUINAZOLINE INHIBITOR
2CGUA:IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING
2CGVA:IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING
2CGWA:IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING
2CGXA:IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING
2CHLA:STRUCTURE OF CASEIN KINASE 1 GAMMA 3
2CMWA:STRUCTURE OF HUMAN CASEIN KINASE 1 GAMMA-1 IN COMPLEX WITH 2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE (CASP TARGET)
2DWBA:AURORA-A KINASE COMPLEXED WITH AMPPNP
2E2BA:; B:CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH INNO-406
2E9NA:STRUCTURE OF H-CHK1 COMPLEXED WITH A767085
2E9OA:STRUCTURE OF H-CHK1 COMPLEXED WITH AA582939
2E9PA:STRUCTURE OF H-CHK1 COMPLEXED WITH A771129
2E9UA:STRUCTURE OF H-CHK1 COMPLEXED WITH A780125
2E9VA:; B:STRUCTURE OF H-CHK1 COMPLEXED WITH A859017
2F4JA:STRUCTURE OF THE KINASE DOMAIN OF AN IMATINIB-RESISTANT ABL MUTANT IN COMPLEX WITH THE AURORA KINASE INHIBITOR VX-680
2FB8A:; B:STRUCTURE OF THE B-RAF KINASE DOMAIN BOUND TO SB-590885
2FSLX:MITOGEN ACTIVATED PROTEIN KINASE P38ALPHA (D176A+F327S) ACTIVATING MUTANT FORM-A
2FSMX:MITOGEN ACTIVATED PROTEIN KINASE P38ALPHA (D176A+F327S) ACTIVATING MUTANT FORM-B
2FSOX:MITOGEN ACTIVATED PROTEIN KINASE P38ALPHA (D176A) ACTIVATING MUTANT
2FSTX:MITOGEN ACTIVATED PROTEIN KINASE P38ALPHA (D176A+F327L) ACTIVATING MUTANT
2G15A:STRUCTURAL CHARACTERIZATION OF AUTOINHIBITED C-MET KINASE
2G2HA:; B:A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
2GDOA:4-(AMINOALKYLAMINO)-3-BENZIMIDAZOLE-QUINOLINONES AS POTENT CHK1 INHIBITORS
2GQGA:; B:X-RAY CRYSTAL STRUCTURE OF DASATINIB (BMS-354825) BOUND TO ACTIVATED ABL KINASE DOMAIN
2GU8A:DISCOVERY OF 2-PYRIMIDYL-5-AMIDOTHIOPHENES AS NOVEL AND POTENT INHIBITORS FOR AKT: SYNTHESIS AND SAR STUDIES
2HIWA:; B:CRYSTAL STRUCTURE OF INACTIVE CONFORMATION ABL KINASE CATALYTIC DOMAIN COMPLEXED WITH TYPE II INHIBITOR
2HXLA:CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 1
2HXQA:CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 2
2HY0A:CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 22
2I0EA:; B:STRUCTURE OF CATALYTIC DOMAIN OF HUMAN PROTEIN KINASE C BETA II COMPLEXED WITH A BISINDOLYLMALEIMIDE INHIBITOR
2I0VA:C-FMS TYROSINE KINASE IN COMPLEX WITH A QUINOLONE INHIBITOR
2I0YA:CFMS TYROSINE KINASE (FGF KID) IN COMPLEX WITH AN ARYLAMIDE INHIBITOR
2I1MA:CFMS TYROSINE KINASE (TIE2 KID) IN COMPLEX WITH AN ARYLAMIDE INHIBITOR
2ITNA:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH AMP-PNP
2ITPA:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH AEE788
2ITQA:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH AFN941
2ITTA:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH AEE788
2ITUA:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH AFN941
2ITVA:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH AMP-PNP
2ITWA:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AFN941
2ITXA:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP
2ITZA:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH IRESSA
2IW8C:STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR
2IZRA:STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR
2IZSA:STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR
2IZTA:STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR
2IZUA:STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR
2J5EA:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR 13-JAB
2J5FA:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR 34-JAB
2J6MA:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AEE788
2J7TA:CRYSTAL STRUCTURE OF HUMAN SERINE THREONINE KINASE-10 BOUND TO SU11274
2J90A:; B:CRYSTAL STRUCTURE OF HUMAN ZIP KINASE IN COMPLEX WITH A TETRACYCLIC PYRIDONE INHIBITOR (PYRIDONE 6)
2JAMA:; B:CRYSTAL STRUCTURE OF HUMAN CALMODULIN-DEPENDENT PROTEIN KINASE I G
2JBOA:PROTEIN KINASE MK2 IN COMPLEX WITH AN INHIBITOR (CRYSTAL FORM-1, SOAKING)
2JC6A:; C:CRYSTAL STRUCTURE OF HUMAN CALMODULIN-DEPENDENT PROTEIN KINASE 1D
2JEDA:; B:THE CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF THE PROTEIN KINASE C THETA IN COMPLEX WITH NVP-XAA228 AT 2.32A RESOLUTION.
2JITA:; B:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION
2JIUA:; B:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION IN COMPLEX WITH AEE788
2NP8A:STRUCTURAL BASIS FOR THE INHIBITION OF AURORA A KINASE BY A NOVEL CLASS OF HIGH AFFINITY DISUBSTITUTED PYRIMIDINE INHIBITORS
2NPQA:A NOVEL LIPID BINDING SITE IN THE P38 ALPHA MAP KINASE
2OBJA:CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH INHIBITOR
2OGVA:CRYSTAL STRUCTURE OF THE AUTOINHIBITED HUMAN C-FMS KINASE DOMAIN
2OJGA:CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE
2OJIA:CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH N-BENZYL-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE
2OJJA:CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH (S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE
2OO8X:SYNTHESIS, STRUCTURAL ANALYSIS, AND SAR STUDIES OF TRIAZINE DERIVATIVES AS POTENT, SELECTIVE TIE-2 INHIBITORS
2OSCA:SYNTHESIS, STRUCTURAL ANALYSIS, AND SAR STUDIES OF TRIAZINE DERIVATIVES AS POTENT, SELECTIVE TIE-2 INHIBITORS
2P4IA:; B:EVOLUTION OF A HIGHLY SELECTIVE AND POTENT 2-(PYRIDIN-2-YL)-1,3,5-TRIAZINE TIE-2 KINASE INHIBITOR
2R2PA:KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 5 (EPHA5)
2REIA:KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 7 (EPHA7)
2V7AA:; B:CRYSTAL STRUCTURE OF THE T315I ABL MUTANT IN COMPLEX WITH THE INHIBITOR PHA-739358
2W1DA:STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
2W1EA:STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
2W1FA:STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
2W1GA:STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
2W4JA:X-RAY STRUCTURE OF A DAP-KINASE 2-277
2W4KA:X-RAY STRUCTURE OF A DAP-KINASE 2-302
2W5AA:HUMAN NEK2 KINASE ADP-BOUND
2W5BA:HUMAN NEK2 KINASE ATPGAMMAS-BOUND
2W5HA:HUMAN NEK2 KINASE APO
2W96B:CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN
2W99B:CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN
2W9FB:CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN
2W9ZB:CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN
2WAJA:CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH A 1-ARYL-3,4-DIHYDROISOQUINOLINE INHIBITOR
2WGJA:X-RAY STRUCTURE OF PF-02341066 BOUND TO THE KINASE DOMAIN OF C-MET
2WIHA:; C:STRUCTURE OF CDK2-CYCLIN A WITH PHA-848125
2WIPA:; C:STRUCTURE OF CDK2-CYCLIN A COMPLEXED WITH 8-ANILINO-1-METHYL-4,5-DIHYDRO-1H-PYRAZOLO[4,3-H] QUINAZOLINE-3-CARBOXYLIC ACID
2WKMA:X-RAY STRUCTURE OF PHA-00665752 BOUND TO THE KINASE DOMAIN OF C-MET
2WMQA:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMRA:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMSA:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMTA:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMUA:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMVA:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMWA:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMXA:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WPAA:; C:OPTIMISATION OF 6,6-DIMETHYL PYRROLO 3,4-C PYRAZOLES: IDENTIFICATION OF PHA-793887, A POTENT CDK INHIBITOR SUITABLE FOR INTRAVENOUS DOSING
2WQBA:STRUCTURE OF THE TIE2 KINASE DOMAIN IN COMPLEX WITH A THIAZOLOPYRIMIDINE INHIBITOR
2WQOA:STRUCTURE OF NEK2 BOUND TO THE AMINOPYRIDINE CCT241950
2WTVA:; B:; C:; D:AURORA-A INHIBITOR STRUCTURE
2WXVA:; C:STRUCTURE OF CDK2-CYCLIN A WITH A PYRAZOLO(4,3-H) QUINAZOLINE-3-CARBOXAMIDE INHIBITOR
2X0GA:X-RAY STRUCTURE OF A DAP-KINASE CALMODULIN COMPLEX
2X6DA:AURORA-A BOUND TO AN INHIBITOR
2X81A:STRUCTURE OF AURORA A IN COMPLEX WITH MLN8054
2X8DA:DISCOVERY OF A NOVEL CLASS OF TRIAZOLONES AS CHECKPOINT KINASE INHIBITORS - HIT TO LEAD EXPLORATION
2X8IA:DISCOVERY OF A NOVEL CLASS OF TRIAZOLONES AS CHECKPOINT KINASE INHIBITORS - HIT TO LEAD EXPLORATION
2XCHA:CRYSTAL STRUCTURE OF PDK1 IN COMPLEX WITH A PYRAZOLOQUINAZOLINE INHIBITOR
2XCKA:CRYSTAL STRUCTURE OF PDK1 IN COMPLEX WITH A PYRAZOLOQUINAZOLINE INHIBITOR
2XEYA:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2XEZA:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2XF0A:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2XIXA:PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-1 FROM CRYSTALLOGRAPHIC FRAGMENT SCREEN
2XIYA:PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-2 FROM CRYSTALLOGRAPHIC FRAGMENT SCREEN
2XIZA:PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-3 FROM CRYSTALLOGRAPHIC FRAGMENT SCREEN
2XJ0A:PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-4 FROM CRYSTALLOGRAPHIC FRAGMENT SCREEN
2XJ1A:PROTEIN KINASE PIM-1 IN COMPLEX WITH SMALL MOLECULE INIBITOR
2XK3A:STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 35
2XK4A:STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 17
2XK6A:STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 36
2XK7A:STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 23
2XK8A:STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 15
2XKCA:STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 14
2XKDA:STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 12
2XKEA:STRUCTURE OF NEK2 BOUND TO AMINIPYRAZINE COMPOUND 5
2XKFA:STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 2
2XNEA:STRUCTURE OF AURORA-A BOUND TO AN IMIDAZOPYRAZINE INHIBITOR
2XNGA:STRUCTURE OF AURORA-A BOUND TO A SELECTIVE IMIDAZOPYRAZINE INHIBITOR
2XNMA:STRUCTURE OF NEK2 BOUND TO CCT
2XNNA:STRUCTURE OF NEK2 BOUND TO CCT242430
2XNOA:STRUCTURE OF NEK2 BOUND TO CCT243779
2XNPA:STRUCTURE OF NEK2 BOUND TO CCT244858
2XRUA:AURORA-A T288E COMPLEXED WITH PHA-828300
2XRWA:LINEAR BINDING MOTIFS FOR JNK AND FOR CALCINEURIN ANTAGONISTICALLY CONTROL THE NUCLEAR SHUTTLING OF NFAT4
2XUUA:CRYSTAL STRUCTURE OF A DAP-KINASE 1 MUTANT
2XYNA:; B:; C:HUMAN ABL2 IN COMPLEX WITH AURORA KINASE INHIBITOR VX-680
2XZSA:; B:DEATH ASSOCIATED PROTEIN KINASE 1 RESIDUES 1-312
2Y0AA:STRUCTURE OF DAPK1 CONSTRUCT RESIDUES 1-304
2Y4PA:; B:; C:; D:DIMERIC STRUCTURE OF DAPK-1 CATALYTIC DOMAIN
2YAKA:STRUCTURE OF DEATH-ASSOCIATED PROTEIN KINASE 1 (DAPK1) IN COMPLEX WITH A RUTHENIUM OCTASPORINE LIGAND (OSV)
2YDIA:DISCOVERY OF CHECKPOINT KINASE INHIBITOR AZD7762 BY STRUCTURE BASED DESIGN AND OPTIMIZATION OF THIOPHENE CARBOXAMIDE UREAS
2YDKA:DISCOVERY OF CHECKPOINT KINASE INHIBITOR AZD7762 BY STRUCTURE BASED DESIGN AND OPTIMIZATION OF THIOPHENE CARBOXAMIDE UREAS
2YERA:SYNTHESIS AND EVALUATION OF TRIAZOLONES AS CHECKPOINT KINASE 1 INHIBITORS
2YEXA:SYNTHESIS AND EVALUATION OF TRIAZOLONES AS CHECKPOINT KINASE 1 INHIBITORS
2YISA:TRIAZOLOPYRIDINE INHIBITORS OF P38 KINASE.
2YIWA:TRIAZOLOPYRIDINE INHIBITORS OF P38 KINASE
2YIXA:TRIAZOLOPYRIDINE INHIBITORS OF P38
2YM3A:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2YM4A:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2YM5A:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2YM6A:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2YM7A:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2YM8A:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2ZAZA:CRYSTAL STRUCTURE OF P38 IN COMPLEX WITH 4-ANILINO QUINOLINE INHIBITOR
2ZB0A:CRYSTAL STRUCTURE OF P38 IN COMPLEX WITH BIPHENYL AMIDE INHIBITOR
2ZB1A:CRYSTAL STRUCTURE OF P38 IN COMPLEX WITH BIPHENYL AMIDE INHIBITOR
2ZDTA:CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH AN ISOQUINOLONE INHIBITOR
2ZDUA:CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH AN ISOQUINOLONE INHIBITOR
2ZJWA:CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA COMPLEXED WITH ELLAGIC ACID
2ZOQA:; B:STRUCTURAL DISSECTION OF HUMAN MITOGEN-ACTIVATED KINASE ERK1
3A2CA:; B:; C:; D:; E:; F:; G:; H:; I:; J:; K:; L:CRYSTAL STRUCTURE OF A PYRAZOLOPYRIMIDINE INHIBITOR COMPLEX BOUND TO MAPKAP KINASE-2 (MK2)
3A4PA:HUMAN C-MET KINASE DOMAIN COMPLEXED WITH 6-BENZYLOXYQUINOLINE INHIBITOR
3AGLA:; B:COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR ARC-1039
3AGMA:COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR ARC-670
3AMYA:CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA COMPLEXED WITH APIGENIN
3AXWA:CRYSTAL STRUCTURE OF HUMAN CK2ALPHA COMPLEXED WITH A POTENT INHIBITOR
3B2TA:; B:STRUCTURE OF PHOSPHOTRANSFERASE
3BBTB:; D:CRYSTAL STRUCTURE OF THE ERBB4 KINASE IN COMPLEX WITH LAPATINIB
3BCEA:; B:; C:CRYSTAL STRUCTURE OF THE ERBB4 KINASE
3BEAA:CFMS TYROSINE KINASE (TIE2 KID) IN COMPLEX WITH A PYRIMIDINOPYRIDONE INHIBITOR
3CC6A:CRYSTAL STRUCTURE OF KINASE DOMAIN OF PROTEIN TYROSINE KINASE 2 BETA (PTK2B)
3CIKA:186-549HUMAN GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS
3CLYA:CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAINS TRAPPED IN TRANS-PHOSPHORYLATION REACTION
3COIA:CRYSTAL STRUCTURE OF P38DELTA KINASE
3CQUA:CRYSTAL STRUCTURE OF AKT-1 COMPLEXED WITH SUBSTRATE PEPTIDE AND INHIBITOR
3CQWA:CRYSTAL STRUCTURE OF AKT-1 COMPLEXED WITH SUBSTRATE PEPTIDE AND INHIBITOR
3CS9A:; B:; C:; D:HUMAN ABL KINASE IN COMPLEX WITH NILOTINIB
3D4QA:; B:PYRAZOLE-BASED INHIBITORS OF B-RAF KINASE
3DFCB:CRYSTAL STRUCTURE OF A GLYCINE-RICH LOOP MUTANT OF THE DEATH ASSOCIATED PROTEIN KINASE CATALYTIC DOMAIN WITH AMPPNP
3DGKA:CRYSTAL STRUCTURE OF A GLYCINE-RICH LOOP MUTANT OF THE DEATH ASSOCIATED PROTEIN KINASE CATALYTIC DOMAIN
3DKOA:COMPLEX BETWEEN THE KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 7 (EPHA7) AND INHIBITOR ALW-II-49-7
3DPKA:CFMS TYROSINE KINASE IN COMPLEX WITH A PYRIDOPYRIMIDINONE INHIBITOR
3E7OA:; B:CRYSTAL STRUCTURE OF JNK2
3E92A:CRYSTAL STRUCTURE OF P38 KINASE IN COMPLEX WITH A BIARYL AMIDE INHIBITOR
3E93A:CRYSTAL STRUCTURE OF P38 KINASE IN COMPLEX WITH A BIARYL AMIDE INHIBITOR
3EH9A:CRYSTAL STRUCTURE OF DEATH ASSOCIATED PROTEIN KINASE COMPLEXED WITH ADP
3EHAA:CRYSTAL STRUCTURE OF DEATH ASSOCIATED PROTEIN KINASE COMPLEXED WITH AMPPNP
3ELJA:JNK1 COMPLEXED WITH A BIS-ANILINO-PYRROLOPYRIMIDINE INHIBITOR.
3ET7A:CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH PF-2318841
3F5GA:CRYSTAL STRUCTURE OF DEATH ASSOCIATED PROTEIN KINASE IN COMPLEX WITH ADP AND MG2+
3F5UA:CRYSTAL STRUCTURE OF THE DEATH ASSOCIATED PROTEIN KINASE IN COMPLEX WITH AMPPNP AND MG2+
3FDNA:STRUCTURE-BASED DRUG DESIGN OF NOVEL AURORA KINASE A INHIBITORS: STRUCTURE BASIS FOR POTENCY AND SPECIFICITY
3FHRA:HIGH RESOLUTION CRYSTAL STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 3 (MK3)-INHIBITOR COMPLEX
3FWQA:; B:INACTIVE CONFORMATION OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT
3FXWA:HIGH RESOLUTION CRYSTAL STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 3/INHIBITOR 2 COMPLEX
3FZOA:CRYSTAL STRUCTURE OF PYK2-APO, PROLINE-RICH TYROSINE KINASE
3FZPA:CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH ATPGS
3FZRA:CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH PF-431396
3FZSA:CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH BIRB796
3FZTA:CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH PF-4618433
3G33A:; C:CRYSTAL STRUCTURE OF CDK4/CYCLIN D3
3GB2A:GSK3BETA INHIBITOR COMPLEX
3GC7A:THE STRUCTURE OF P38ALPHA IN COMPLEX WITH A DIHYDROQUINAZOLINONE
3GC8A:; B:THE STRUCTURE OF P38BETA C162S IN COMPLEX WITH A DIHYDROQUINAZOLINONE
3GC9A:; B:THE STRUCTURE OF P38BETA C119S, C162S IN COMPLEX WITH A DIHYDROQUINAZOLINONE INHIBITOR
3GENA:THE 1.6 A CRYSTAL STRUCTURE OF HUMAN BRUTON'S TYROSINE KINASE BOUND TO A PYRROLOPYRIMIDINE-CONTAINING COMPOUND
3GP0A:CRYSTAL STRUCTURE OF HUMAN MITOGEN ACTIVATED PROTEIN KINASE 11 (P38 BETA) IN COMPLEX WITH NILOTINIB
3GQIA:CRYSTAL STRUCTURE OF ACTIVATED RECEPTOR TYROSINE KINASE IN COMPLEX WITH SUBSTRATES
3GQLA:; B:; C:CRYSTAL STRUCTURE OF ACTIVATED RECEPTOR TYROSINE KINASE IN COMPLEX WITH SUBSTRATES
3GU4A:CRYSTAL STRUCTURE OF DAPKQ23V-AMPPNP
3GU5A:CRYSTAL STRUCTURE OF DAPKQ23V-AMPPNP-MG2+
3GU6A:CRYSTAL STRUCTURE OF DAPKQ23V-ADP
3GU7A:CRYSTAL STRUCTURE OF DAPKQ23V-ADP-MG2+
3GU8A:CRYSTAL STRUCTURE OF DAPKL93G WITH N6-CYCLOPENTYLADENOSINE
3GUBA:CRYSTAL STRUCTURE OF DAPKL93G COMPLEXED WITH N6-(2-PHENYLETHYL)ADENOSINE
3GVUA:THE CRYSTAL STRUCTURE OF HUMAN ABL2 IN COMPLEX WITH GLEEVEC
3H3CA:CRYSTAL STRUCTURE OF PYK2 IN COMPLEX WITH SULFOXIMINE-SUBSTITUTED TRIFLUOROMETHYLPYRIMIDINE ANALOG
3H9RA:CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF TYPE I ACTIVIN RECEPTOR (ACVR1) IN COMPLEX WITH FKBP12 AND DORSOMORPHIN
3HA6A:CRYSTAL STRUCTURE OF AURORA A IN COMPLEX WITH TPX2 AND COMPOUND 10
3HL7A:CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH SD-0006
3HLLA:CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH PH-797804
3HMIA:THE CRYSTAL STRUCTURE OF HUMAN ABL2 IN COMPLEX WITH 5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE
3HP2A:CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH A PYRIDINONE COMPOUND
3HP5A:CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH A PYRIMIDOPYRIDAZINONE COMPOUND
3I5ZA:CRYSTAL STRUCTURE OF ERK2 BOUND TO (S)-N-(2-HYDROXY-1-PHENYLETHYL)-4-(5-METHYL-2-(PHENYLAMINO)PYRIMIDIN-4-YL)-1H-PYRROLE-2-CARBOXAMIDE
3I60A:CRYSTAL STRUCTURE OF ERK2 BOUND TO (S)-4-(2-(2-CHLOROPHENYLAMINO)-5-METHYLPYRIMIDIN-4-YL)-N-(2-HYDROXY-1-PHENYLETHYL)-1H-PYRROLE-2-CARBOXAMIDE
3IDPA:; B:B-RAF V600E KINASE DOMAIN IN COMPLEX WITH AN AMINOISOQUINOLINE INHIBITOR
3II5A:; B:THE COMPLEX OF WILD-TYPE B-RAF WITH PYRAZOLO PYRIMIDINE INHIBITOR
3IW4A:; B:; C:CRYSTAL STRUCTURE OF PKC ALPHA IN COMPLEX WITH NVP-AEB071
3K54A:STRUCTURES OF HUMAN BRUTON'S TYROSINE KINASE IN ACTIVE AND INACTIVE CONFORMATIONS SUGGESTS A MECHANISM OF ACTIVATION FOR TEC FAMILY KINASES.
3K5UA:IDENTIFICATION, SAR STUDIES AND X-RAY COCRYSTAL ANALYSIS OF A NOVEL FURANO-PYRIMIDINE AURORA KINASE A INHIBITOR
3KCFA:; B:; C:; D:; E:CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A PYRAZOLONE INHIBITOR
3KF7A:CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH A TRIAZOLOPYRIMIDINE COMPOUND
3KRJA:CFMS TYROSINE KINASE IN COMPLEX WITH 4-CYANO-1H-IMIDAZOLE-2-CARBOXYLIC ACID (2-CYCLOHEX-1-ENYL-4-PIPERIDIN-4-YL-PHENYL)-AMIDE
3KRLA:CFMS TYROSINE KINASE IN COMPLEX WITH 5-CYANO-FURAN-2-CARBOXYLIC ACID [4-(4-METHYL-PIPERAZIN-1-YL)-2-PIPERIDIN-1-YL-PHENYL]-AMIDE
3KRWA:186-549HUMAN GRK2 IN COMPLEX WITH GBETGAMMA SUBUNITS AND BALANOL (SOAK)
3KRXA:186-549HUMAN GRK2 IN COMPLEX WITH GBETGAMMA SUBUNITS AND BALANOL (CO-CRYSTAL)
3KULA:; B:KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 8 (EPHA8)
3L8PA:CRYSTAL STRUCTURE OF CYTOPLASMIC KINASE DOMAIN OF TIE2 COMPLEXED WITH INHIBITOR CEP11207
3LAUA:CRYSTAL STRUCTURE OF AURORA2 KINASE IN COMPLEX WITH A GSK3BETA INHIBITOR
3LCDA:INHIBITOR BOUND TO A DFG-IN STRUCTURE OF THE KINASE DOMAIN OF CSF-1R
3M11A:CRYSTAL STRUCTURE OF AURORA A KINASE COMPLEXED WITH INHIBITOR
3MBLA:CRYSTAL STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK 1) IN COMPLEX WITH LIGAND AND MGADP
3MDYA:; C:CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE BONE MORPHOGENETIC PROTEIN RECEPTOR TYPE-1B (BMPR1B) IN COMPLEX WITH FKBP12 AND LDN-193189
3MTFA:; B:CRYSTAL STRUCTURE OF THE ACVR1 KINASE IN COMPLEX WITH A 2-AMINOPYRIDINE INHIBITOR
3MV5A:CRYSTAL STRUCTURE OF AKT-1-INHIBITOR COMPLEXES
3MVHA:CRYSTAL STRUCTURE OF AKT-1-INHIBITOR COMPLEXES
3MVJA:; B:; E:HUMAN CYCLIC AMP-DEPENDENT PROTEIN KINASE PKA INHIBITOR COMPLEX
3MY0A:; B:; C:; D:; E:; F:; G:; H:; I:; J:; K:; L:; M:; N:; O:; P:; Q:; R:; S:; T:; U:; V:; W:; X:CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN-193189
3NAXA:PDK1 IN COMPLEX WITH INHIBITOR MP7
3NGAA:; B:HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH CX-4945
3NLBA:NOVEL KINASE PROFILE HIGHLIGHTS THE TEMPORAL BASIS OF CONTEXT DEPENDENT CHECKPOINT PATHWAYS TO CELL DEATH
3NPCA:; B:CRYSTAL STRUCTURE OF JNK2 COMPLEXED WITH BIRB796
3NX8A:HUMAN CAMP DEPENDENT PROTEIN KINASE IN COMPLEX WITH PHENOL
3O2MA:; B:CRYSTAL STRUCTURE OF JNK1-ALPHA1 ISOFORM COMPLEX WITH A BIARYL TETRAZOL (A-82118)
3OCBA:; B:AKT1 KINASE DOMAIN WITH PYRROLOPYRIMIDINE INHIBITOR
3OCSA:CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE IN COMPLEX WITH INHIBITOR CGI1746
3OCTA:CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE MUTANT V555R IN COMPLEX WITH DASATINIB
3OFMA:STRUCTURE OF A HUMAN CK2ALPHA PRIME, THE PARALOG ISOFORM OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 FROM HOMO SAPIENS
3OG7A:; B:B-RAF KINASE V600E ONCOGENIC MUTANT IN COMPLEX WITH PLX4032
3OOGA:HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH A SMALL FRAGMENT
3OOMA:CRYSTAL STRUCTURE OF THE ACVR1 KINASE DOMAIN IN COMPLEX WITH THE IMIDAZO[1,2-B]PYRIDAZINE INHIBITOR K00507
3OW4A:; B:DISCOVERY OF DIHYDROTHIENO- AND DIHYDROFUROPYRIMIDINES AS POTENT PAN AKT INHIBITORS
3OXTA:HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH AN INHIBITOR
3P08A:; B:CRYSTAL STRUCTURE OF THE HUMAN BTK KINASE DOMAIN
3P9JA:AURORA A KINASE DOMAIN WITH PHTHALAZINONE PYRAZOLE INHIBITOR
3PIXA:CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-ISOPROPYL-7-(4-METHYL-PIPERAZIN-1-YL)-4-(5-METHYL-2H-PYRAZOL-3-YLAMINO)-2H-PHTHALAZIN-1-ONE
3PIYA:CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH R406
3PIZA:CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH (5-AMINO-1-O-TOLYL-1H-PYRAZOL-4-YL)-[3-(1-METHANESULFONYL-PIPERIDIN-4-YL)-PHENYL]-METHANONE
3PJ1A:CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 3-(2,6-DICHLORO-PHENYL)-7-[4-(2-DIETHYLAMINO-ETHOXY)-PHENYLAMINO]-1-METHYL-3,4-DIHYDRO-1H-PYRIMIDO[4,5-D]PYRIMIDIN-2-ONE
3PJ2A:CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-[4-(2-DIETHYLAMINO-ETHOXY)-PHENYLAMINO]-6-(4-FLUORO-PHENOXY)-8-METHYL-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE
3PJ3A:CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-METHYL-5-[(E)-(3-PHENYL-ACRYLOYL)AMINO]-N-(2-PHENYL-3H-IMIDAZO[4,5-B]PYRIDIN-6-YL)-BENZAMIDE
3PLSA:RON IN COMPLEX WITH LIGAND AMP-PNP
3POOA:HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH AN INHIBITOR
3PP0A:; B:CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN HER2 (ERBB2).
3PP1A:CRYSTAL STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK 1) IN COMPLEX WITH LIGAND AND MGATP
3PRFA:; B:CRYSTAL STRUCTURE OF HUMAN B-RAF KINASE DOMAIN IN COMPLEX WITH A NON-OXIME FUROPYRIDINE INHIBITOR
3PXKA:; B:FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH PYRROLO[2,3-D]THIAZOLE
3PYYA:; B:DISCOVERY AND CHARACTERIZATION OF A CELL-PERMEABLE, SMALL-MOLECULE C-ABL KINASE ACTIVATOR THAT BINDS TO THE MYRISTOYL BINDING SITE
3PZEA:JNK1 IN COMPLEX WITH INHIBITOR
3Q4UA:; B:; C:; D:CRYSTAL STRUCTURE OF THE ACVR1 KINASE DOMAIN IN COMPLEX WITH LDN-193189
3QKKA:SPIROCHROMANE AKT INHIBITORS
3QKLA:SPIROCHROMANE AKT INHIBITORS
3QKMA:SPIROCYCLIC SULFONAMIDES AS AKT INHIBITORS
3QRIA:; B:THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN IN COMPLEX WITH DCC-2036
3QRJA:; B:THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN T315I MUTANT IN COMPLEX WITH DCC-2036
3QRKA:THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN IN COMPLEX WITH DP-987
3R1NA:MK3 KINASE BOUND TO COMPOUND 5B
3R21A:DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION OF PYRAZOLOPYRIDINE-SULFONAMIDES AS POTENT MULTIPLE-MITOTIC KINASE (MMK) INHIBITORS (PART I)
3RI1A:; B:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF FGFR2 KINASE IN COMPLEX WITH ARQ 069
3ROCA:CRYSTAL STRUCTURE OF HUMAN P38 ALPHA COMPLEXED WITH A PYRIMIDINONE COMPOUND
3SA0A:COMPLEX OF ERK2 WITH NORATHYRIOL
3SHEA:NOVEL ATP-COMPETITIVE MK2 INHIBITORS WITH POTENT BIOCHEMICAL AND CELL-BASED ACTIVITY THROUGHOUT THE SERIES
3SLSA:; B:CRYSTAL STRUCTURE OF HUMAN MEK-1 KINASE IN COMPLEX WITH UCB1353770 AND AMPPNP
3SXRA:; B:CRYSTAL STRUCTURE OF BMX NON-RECEPTOR TYROSINE KINASE COMPLEX WITH DASATINIB
3SXSA:CRYSTAL STRUCTURE OF BMX NON-RECEPTOR TYROSINE KINASE COMPLEXED WITH PP2
3TXOA:PKC ETA KINASE IN COMPLEX WITH A NAPHTHYRIDINE
3U6JA:CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRAZOLONE INHIBITOR
3UE4A:; B:STRUCTURAL AND SPECTROSCOPIC ANALYSIS OF THE KINASE INHIBITOR BOSUTINIB BINDING TO THE ABL TYROSINE KINASE DOMAIN
3UYSA:; B:; C:; D:CRYSTAL STRUCTURE OF APO HUMAN CK1D
3UYTA:; B:; C:; D:CRYSTAL STRUCTURE OF CK1D WITH PF670462 FROM P1 CRYSTAL FORM
3UZPA:; B:CRYSTAL STRUCTURE OF CK1D WITH PF670462 FROM P21 CRYSTAL FORM
3V5WA:186-549HUMAN G PROTEIN-COUPLED RECEPTOR KINASE 2 IN COMPLEX WITH SOLUBLE GBETAGAMMA SUBUNITS AND PAROXETINE
3V6RA:; B:DISCOVERY OF POTENT AND SELECTIVE COVALENT INHIBITORS OF JNK
3V6SA:; B:DISCOVERY OF POTENT AND SELECTIVE COVALENT INHIBITORS OF JNK
3VNTA:CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN VEGFR2 WITH A [1, 3]THIAZOLO[5,4-B]PYRIDINE DERIVATIVE
3VO3A:CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN VEGFR2 WITH IMIDAZO[1, 2-B]PYRIDAZINE DERIVATIVE
3W55A:THE STRUCTURE OF ERK2 IN COMPLEX WITH FR148083
3W8QA:STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1)
3ZBXA:X-RAY STRUCTURE OF C-MET KINASE IN COMPLEX WITH INHIBITOR 6-((6-(4-FLUOROPHENYL)-(1,2,4)TRIAZOLO(4,3-B)(1,2,4)TRIAZIN-3-YL)METHYL)QUINOLINE.
3ZC5A:X-RAY STRUCTURE OF C-MET KINASE IN COMPLEX WITH INHIBITOR ( S)-6-(1-(6-(1-METHYL-1H-PYRAZOL-4-YL)-(1,2,4)TRIAZOLO(4,3-B)PYRIDAZIN-3-YL)ETHYL)QUINOLINE.
3ZCLA:X-RAY STRUCTURE OF C-MET KINASE IN COMPLEX WITH INHIBITOR ( S)-3-(1-(1H-PYRROLO(2,3-B)PYRIDIN-3-YL)ETHYL)-N-ISOPROPYL-( 1,2,4)TRIAZOLO(4,3-B)PYRIDAZIN-6-AMINE
3ZLSA:CRYSTAL STRUCTURE OF MEK1 IN COMPLEX WITH FRAGMENT 6
3ZLWA:CRYSTAL STRUCTURE OF MEK1 IN COMPLEX WITH FRAGMENT 3
3ZLXA:CRYSTAL STRUCTURE OF MEK1 IN COMPLEX WITH FRAGMENT 18
3ZLYA:CRYSTAL STRUCTURE OF MEK1 IN COMPLEX WITH FRAGMENT 8
3ZM4A:CRYSTAL STRUCTURE OF MEK1 IN COMPLEX WITH FRAGMENT 1
3ZS5A:STRUCTURAL BASIS FOR KINASE SELECTIVITY OF THREE CLINICAL P38ALPHA INHIBITORS
3ZSGA:X-RAY STRUCTURE OF P38ALPHA BOUND TO TAK-715
3ZSHA:X-RAY STRUCTURE OF P38ALPHA BOUND TO SCIO-469
3ZSIA:X-RAY STRUCTURE OF P38ALPHA BOUND TO VX-745
3ZXTA:; B:; C:; D:DIMERIC STRUCTURE OF DAPK-1 CATALYTIC DOMAIN IN COMPLEX WITH AMPPCP-MG
3ZXZA:X-RAY STRUCTURE OF PF-04217903 BOUND TO THE KINASE DOMAIN OF C-MET
3ZYAA:HUMAN P38 MAP KINASE IN COMPLEX WITH 2-AMINO-PHENYLAMINO-DIBENZOSUBERONE
3ZZEA:CRYSTAL STRUCTURE OF C-MET KINASE DOMAIN IN COMPLEX WITH N'-((3Z)-4-CHLORO-7-METHYL-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)-2-(4-HYDROXYPHENYL)PROPANOHYDRAZIDE
4A4XA:NEK2-EDE BOUND TO CCT248662
4AA0A:P38ALPHA MAP KINASE BOUND TO CMPD 2
4ACCA:; B:GSK3B IN COMPLEX WITH INHIBITOR
4ACDA:; B:GSK3B IN COMPLEX WITH INHIBITOR
4ACGA:; B:GSK3B IN COMPLEX WITH INHIBITOR
4ACHA:; B:GSK3B IN COMPLEX WITH INHIBITOR
4AE6A:; B:STRUCTURE AND FUNCTION OF THE HUMAN SPERM-SPECIFIC ISOFORM OF PROTEIN KINASE A (PKA) CATALYTIC SUBUNIT CALPHA 2
4AE9A:; B:STRUCTURE AND FUNCTION OF THE HUMAN SPERM-SPECIFIC ISOFORM OF PROTEIN KINASE A (PKA) CATALYTIC SUBUNIT C ALPHA 2
4AF3A:HUMAN AURORA B KINASE IN COMPLEX WITH INCENP AND VX-680
4AFEA:NEK2 BOUND TO HYBRID COMPOUND 21
4AFJA:; B:5-ARYL-4-CARBOXAMIDE-1,3-OXAZOLES: POTENT AND SELECTIVE GSK-3 INHIBITORS
4AG8A:CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH AXITINIB (AG-013736) (N-METHYL-2-(3-((E)-2-PYRIDIN-2-YL-VINYL)-1H- INDAZOL-6-YLSULFANYL)-BENZAMIDE)
4AGCA:CRYSTAL STRUCTURE OF VEGFR2 (JUXTAMEMBRANE AND KINASE DOMAINS) IN COMPLEX WITH AXITINIB (AG-013736) (N-METHYL-2-( 3-((E)-2-PYRIDIN-2-YL-VINYL)-1H-INDAZOL-6-YLSULFANYL)-BENZAMIDE)
4AGDA:CRYSTAL STRUCTURE OF VEGFR2 (JUXTAMEMBRANE AND KINASE DOMAINS) IN COMPLEX WITH SUNITINIB (SU11248) (N-2-DIETHYLAMINOETHYL)-5-((Z)-(5-FLUORO-2-OXO-1H-INDOL-3-YLIDENE)METHYL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE)
4ALUA:BENZOFUROPYRIMIDINONE INHIBITORS OF PIM-1
4AOIA:CRYSTAL STRUCTURE OF C-MET KINASE DOMAIN IN COMPLEX WITH 4-( 3-((1H-PYRROLO(2,3-B)PYRIDIN-3-YL)METHYL)-(1,2,4)TRIAZOLO( 4,3-B)(1,2,4) TRIAZIN-6-YL)BENZONITRILE
4AOTA:; B:CRYSTAL STRUCTURE OF HUMAN SERINE THREONINE KINASE-10 (LOK) BOUND TO GW830263A
4AP7A:CRYSTAL STRUCTURE OF C-MET KINASE DOMAIN IN COMPLEX WITH 4-( (6-(4-FLUOROPHENYL)-(1,2,4)TRIAZOLO(4,3-B)(1,2,4)TRIAZIN-3-YL)METHYL) PHENOL
4ARKA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MAP KINASE KINASE 1 (MEK1) IN COMPLEX WITH A SMALL MOLECULE INHIBITOR AND ADP
4AS0A:CYCLOMETALATED PHTHALIMIDES AS PROTEIN KINASE INHIBITORS
4ASDA:CRYSTAL STRUCTURE OF VEGFR2 (JUXTAMEMBRANE AND KINASE DOMAINS) IN COMPLEX WITH SORAFENIB (BAY 43-9006)
4ASEA:CRYSTAL STRUCTURE OF VEGFR2 (JUXTAMEMBRANE AND KINASE DOMAINS) IN COMPLEX WITH TIVOZANIB (AV-951)
4AU8A:; B:CRYSTAL STRUCTURE OF COMPOUND 4A IN COMPLEX WITH CDK5, SHOWING AN UNUSUAL BINDING MODE TO THE HINGE REGION VIA A WATER MOLECULE
4AWIA:HUMAN JNK1ALPHA KINASE WITH 4-PHENYL-7-AZAINDOLE IKK2 INHIBITOR.
4B0GA:COMPLEX OF AURORA-A BOUND TO AN IMIDAZOPYRIDINE-BASED INHIBITOR
4B4LA:CRYSTAL STRUCTURE OF AN ARD DAP-KINASE 1 MUTANT
4BC6A:CRYSTAL STRUCTURE OF HUMAN SERINE THREONINE KINASE-10 BOUND TO NOVEL BOSUTINIB ISOFORM 1, PREVIOUSLY THOUGHT TO BE BOSUTINIB
4BCFA:STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2-AMINO-4-HETEROARYL-PYRIMIDINE INHIBITOR
4BCGA:STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2-AMINO-4-HETEROARYL-PYRIMIDINE INHIBITOR
4BCHA:STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2-AMINO-4-HETEROARYL-PYRIMIDINE INHIBITOR
4BCIA:STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2-AMINO-4-HETEROARYL-PYRIMIDINE INHIBITOR
4BCJA:STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2-AMINO-4-HETEROARYL-PYRIMIDINE INHIBITOR
4BGGA:; B:; C:; D:CRYSTAL STRUCTURE OF THE ACVR1 KINASE IN COMPLEX WITH LDN-213844
4BYIA:AURORA A KINASE BOUND TO A HIGHLY SELECTIVE IMIDAZOPYRIDINE INHIBITOR
4BYJA:AURORA A KINASE BOUND TO A HIGHLY SELECTIVE IMIDAZOPYRIDINE INHIBITOR
4BZNA:CRYSTAL STRUCTURE OF PIM1 IN COMPLEX WITH A PYRROLO(1,2-A) PYRAZINONE INHIBITOR
4BZOA:CRYSTAL STRUCTURE OF PIM1 IN COMPLEX WITH A PYRROLO-PYRAZINONE INHIBITOR
4C02A:CRYSTAL STRUCTURE OF HUMAN ACVR1 (ALK2) IN COMPLEX WITH FKBP12.6 AND DORSOMORPHIN
4DBNA:; B:CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN B-RAF WITH A [1, 3]THIAZOLO[5,4-B]PYRIDINE DERIVATIVE
4DEAA:AURORA A IN COMPLEX WITH YL1-038-18
4DHFA:; B:STRUCTURE OF AURORA A MUTANT BOUND TO BIOGENIDEC CPD 15
4DYMA:CRYSTAL STRUCTURE OF THE ACVR1 KINASE DOMAIN IN COMPLEX WITH THE IMIDAZO[1,2-B]PYRIDAZINE INHIBITOR K00135
4E26A:; B:BRAF IN COMPLEX WITH AN ORGANIC INHIBITOR 7898734
4EKLA:AKT1 WITH GDC0068
4EQUA:; B:HUMAN STK-10 (LOK) KINASE DOMAIN IN DFG-OUT CONFORMATION WITH INHIBITOR DSA-7
4EXU  [entry was replaced by entry 4YNO without any SCOP domain information]
4EYJA:MAPK13 COMPLEX WITH INHIBITOR
4EYMA:MAPK13 COMPLEX WITH INHIBITOR
4EZ5A:CDK6 (MONOMERIC) IN COMPLEX WITH INHIBITOR
4FC0A:; B:CRYSTAL STRUCTURE OF HUMAN KINASE DOMAIN OF B-RAF WITH A DFG-OUT INHIBITOR
4FG7A:CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE I 1-293 IN COMPLEX WITH ATP
4FG8A:; B:CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE I 1-315 IN COMPLEX WITH ATP
4FG9A:; B:CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE I 1-320 IN COMPLEX WITH ATP
4FGBA:CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE I APO FORM
4FUXA:CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH E75
4FUYA:CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK2
4FV0A:CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK3
4FV1A:CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK4
4FV2A:CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK5
4FV3A:CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK6
4FV4A:CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK7
4FV5A:CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK9
4FV6A:CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH E57
4FV7A:CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH E94
4FV8A:CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH E63
4FV9A:CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH E71
4G16A:CRYSTAL STRUCTURE OF CK1G3 WITH 2-[(4-{[3-(TRIFLUOROMETHYL)PYRIDIN2-YL]OXY}PHENYL)AMINO]-1H-BENZIMIDAZOLE-6-CARBONITRILE
4G17A:CRYSTAL STRUCTURE OF CK1G3 WITH 2-[(4-TERT-BUTYLPHENYL)AMINO]-1H-BENZIMIDAZOLE-6-CARBONITRILE
4G5JA:CRYSTAL STRUCTURE OF EGFR KINASE IN COMPLEX WITH BIBW2992
4G5PA:; B:CRYSTAL STRUCTURE OF EGFR KINASE T790M IN COMPLEX WITH BIBW2992
4G6NA:CRYSTAL STRUCTURE OF THE ERK2
4G6OA:CRYSTAL STRUCTURE OF THE ERK2
4GG5A:CRYSTAL STRUCTURE OF CMET IN COMPLEX WITH NOVEL INHIBITOR
4GG7A:CRYSTAL STRUCTURE OF CMET IN COMPLEX WITH NOVEL INHIBITOR
4GV1A:PKB ALPHA IN COMPLEX WITH AZD5363
4H1JA:CRYSTAL STRUCTURE OF PYK2 WITH THE PYRAZOLE 13A
4H1MA:CRYSTAL STRUCTURE OF PYK2 WITH THE INDOLE 10C
4H58A:; B:; C:BRAF IN COMPLEX WITH COMPOUND 3
4HGLA:CRYSTAL STRUCTURE OF CK1G3 WITH COMPOUND 1
4HGSA:CRYSTAL STRUCTURE OF CK1GS WITH COMPOUND 13
4HNIA:; B:CRYSTAL STRUCTURE OF CK1E IN COMPLEX WITH PF4800567
4HOKA:; C:; E:; G:; I:; K:; M:; O:; Q:; S:; U:; W:CRYSTAL STRUCTURE OF APO CK1E
4HVSA:CRYSTAL STRUCTURE OF KIT KINASE DOMAIN WITH A SMALL MOLECULE INHIBITOR, PLX647
4HW7A:CRYSTAL STRUCTURE OF FMS KINASE DOMAIN WITH A SMALL MOLECULAR INHIBITOR, PLX647-OME
4I41A:CRYSTAL STRUCTURE OF HUMAN SER/THR KINASE PIM1 IN COMPLEX WITH MITOXANTRONE
4IMYA:; C:; E:THE AFF4 SCAFFOLD BINDS HUMAN P-TEFB ADJACENT TO HIV TAT
4IZ5A:; B:; C:; D:STRUCTURE OF THE COMPLEX BETWEEN ERK2 PHOSPHOMIMETIC MUTANT AND PEA-15
4IZ7A:; C:STRUCTURE OF NON-PHOSPHORYLATED ERK2 BOUND TO THE PEA-15 DEATH EFFECTOR DOMAIN
4IZAA:; C:STRUCTURE OF DUALLY PHOSPHORYLATED ERK2 BOUND TO THE PEA-15 DEATH EFFECTOR DOMAIN
4K33A:CRYSTAL STRUCTURE OF FGF RECEPTOR 3 (FGFR3) KINASE DOMAIN HARBORING THE K650E MUTATION, A GAIN-OF-FUNCTION MUTATION RESPONSIBLE FOR THANATOPHORIC DYSPLASIA TYPE II AND SPERMATOCYTIC SEMINOMA
4KSPA:; B:CRYSTAL STRUCTURE OF HUMAN B-RAF BOUND TO A DFG-OUT INHIBITOR TAK-632
4L7FA:CO-CRYSTAL STRUCTURE OF JNK1 AND AX13587
4NM5A:CRYSTAL STRUCTURE OF GSK-3/AXIN COMPLEX BOUND TO PHOSPHORYLATED WNT RECEPTOR LRP6 C-MOTIF
4NWMA:; B:CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE COMPLEXED WITH BMS-809959 AKA 4-TERT-BUTYL-N-[2-ME THYL-3-(6-{[4-(MORPHOLINE-4-CARBONYL)PHENYL]AMINO}-9H- PURIN-2-YL)PHENYL]BENZAMIDE